Status:
COMPLETED
Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome
Lead Sponsor:
Samsung Medical Center
Conditions:
Prader-Willi Syndrome
Obesity
Eligibility:
All Genders
6-18 years
Brief Summary
Context: Prader-Willi syndrome (PWS) is a genetic disorder characterized by childhood-onset obesity and endocrine dysfunction that leads to cardiovascular disability and early death within the first 3...
Detailed Description
Main outcome measures: Correlation of IMT with age, standard deviation score of BMI (BMI-SDS), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), C-reactive protein...
Eligibility Criteria
Inclusion
- obesity with PWS
Exclusion
- chronic disease
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01479322
Start Date
January 1 2007
End Date
July 1 2007
Last Update
November 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.